Every week, MedCity News highlights the best of its MedCitizens: syndication partners and MedCity News readers who discuss life science current events on MedCityNews.com.
Now here’s the best of what YOU had to say:
Social media in healthcare: medical device companies’ use rising. “A new survey shows that the use of social networking hubs like Twitter, Linkedin and Facebook by medical device companies appears to be on the uptick, at least in Massachusetts.”
With the Rise of AI, What IP Disputes in Healthcare Are Likely to Emerge?
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
Healthcare should not abandon cloud computing despite its problems. The reason to use the public cloud is so that my limited staff can spend their time innovating, creating infrastructure and applications that the public cloud has not yet envisioned or refuses to support because of regulatory requirements (such as HIPAA). Despite the black cloud of the past two weeks, the future of the cloud, tempered by a dose of reality to reset expectations, is bright.
New Prescription Drugs. “Motivated by government incentives, and in the hopes of reaching new markets and facing less competition after patents expire, manufacturers introduced highly specialized products in the past year. Here are some of the most notable recent prescription drugs that have come into the market.”
Boston Scientific shares sold, Medtronic shares bought by Paulson. “The New York-based hedge fund has been steadily selling off its BSX shares over the last year. It now has just 15 million shares, valued at $107.9 million, according to regulatory filings.”
Chris Seper runs MedCityNews.com and contributes regularly to the site. He is the vice president of healthcare for Breaking Media, MedCity's corporate owners. Reach him at [email protected].